FindTrial
Sign In

Piracetam for Treatment of Cocaine Addiction, Phase II - 4

Piracetam for Treatment of Cocaine Addiction, Phase II

Status
Withdrawn
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00000199
Enrollment
0
Registered
1999-09-21
Start date
Unknown
Completion date
Unknown
Last updated
2017-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cocaine-Related Disorders

Keywords

cocaine

Brief summary

The purpose of this study is to follow patients in Phase I of an inpatient study in an eight week open label assessment of piracetam in an outpatient treatment program.

Interventions

DRUGPiracetam

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
University of Pennsylvania
Lead SponsorOTHER

Study design

Primary purpose
TREATMENT

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

Please contact site for information.

Design outcomes

Primary

MeasureTime frame
Drug use—
Adverse effects—
Clinical status—

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026